Cross-fund · 4 holders
VTGN
VISTAGEN THERAPEUTICS INC
CUSIP 92840H400
4
Tracked holders
$2.0M
Aggregate value
3,192,549
Shares
4
Active funds
Funds holding VTGN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $1.2M | — | +137,003 | +8.1% |
| Millennium | Multi-Strategy | Q1 2026 | $368,277 | — | +447,359 | +227.0% |
| BlackRock | Institutional | Q1 2026 | $256,322 | — | +25,748 | +6.1% |
| Citadel | Multi-Strategy | Q1 2026 | $157,106 | — | -576,800 | -67.7% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.